Stock QDEL QUIDELORTHO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News QuidelOrtho Corporation

Equities

QDEL

US2197981051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
38.71 USD -3.95% Intraday chart for QuidelOrtho Corporation -12.00% -47.48%
Apr. 02 QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay MT
Apr. 02 QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ROSEN, A LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
NE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
BU
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
BU
QuidelOrtho To Report First Quarter 2024 Financial Results
BU
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
BU
QDEL Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
BU
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives
BU
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Company and Certain Executives
BU
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
PR
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
BU
QuidelOrtho Receives FDA 510(K) Clearance for Its QuickVue COVID-19 Test
AQ
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
PR
QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay
MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test
MT
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
BU
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test
CI
QDEL INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
NE
QDEL LOSS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
NE
QDEL LOSS ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages QuidelOrtho Corporation Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - QDEL
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QDEL Stock
  4. News QuidelOrtho Corporation